We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Environment Secretary opens international meeting on business and biodiversity
Screening laboratories can use these template letters to contact clinicians about a presumed positive newborn screening result for inherited metabolic diseases.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight management...
An annual publication on local sites across England in positive conservation.
This publication contains information on local sites (ie sites designated locally for their substantive nature conservation importance, either for wildlife or geology). These sites are being managed so as to preserve their nature conservation interest (ie. are in “positive conservation...
Guidance for Applicants wishing to apply for a Promising Innovative Medicines designation, pre-submission meeting or an EAMS Scientific Opinion.
OFSP is a disruptive innovation to address the high levels of vitamin A deficiency among children under 5 years of age in sub-Saharan Africa
Guidance on conditional marketing authorisations, exceptional circumstances marketing authorisations and national scientific advice.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).